What is the treatment for high bilirubin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of High Bilirubin Levels

Critical Distinction: Neonatal vs. Adult Hyperbilirubinemia

The treatment of high bilirubin depends entirely on whether the patient is a neonate (≥35 weeks gestation) or an adult, as these represent fundamentally different clinical scenarios with distinct management pathways. 1, 2


NEONATAL HYPERBILIRUBINEMIA (≥35 weeks gestation)

Emergency Thresholds

If total serum bilirubin (TSB) ≥25 mg/dL at any time, this is a medical emergency requiring immediate hospital admission for intensive phototherapy. 1, 2

  • Immediate exchange transfusion is indicated for any jaundiced infant manifesting signs of acute bilirubin encephalopathy (hypertonia, arching, retrocollis, opisthotonos, fever, high-pitched cry), even if TSB is falling 1
  • Exchange transfusion should only be performed by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities 2, 3

Phototherapy Initiation

Intensive phototherapy should be initiated based on age-specific TSB thresholds and risk factors (see AAP nomogram in guidelines): 1

  • Higher risk infants (isoimmune hemolytic disease, G6PD deficiency, asphyxia, sepsis, acidosis, albumin <3.0 g/dL): Lower thresholds apply 1
  • Medium risk infants (≥38 weeks + well, or 35-37⁶/₇ weeks + well): Intermediate thresholds 1
  • Lower risk infants (≥38 weeks + well): Higher thresholds 1

Intensive Phototherapy Specifications

"Intensive phototherapy" requires irradiance ≥30 μW/cm²/nm in the blue-green spectrum (430-490 nm) delivered to maximum infant surface area: 1

  • Line bassinet/incubator with aluminum foil or white material if TSB approaches exchange transfusion levels 1
  • Expected TSB decline: 30-40% reduction in first 24 hours with intensive phototherapy; most significant decline in first 4-6 hours 1
  • With extremely high levels (>30 mg/dL), expect decline of up to 10 mg/dL within hours 1

Phototherapy Management Details

  • Continue breastfeeding during phototherapy whenever possible 1
  • Supplement with expressed breast milk or formula if intake inadequate, weight loss excessive, or infant dehydrated 1
  • Phototherapy should be continuous (not intermittent) when TSB approaches exchange transfusion zone 1
  • Brief interruptions for feeding or parental visits are acceptable if TSB not critically elevated 1

Discontinuing Phototherapy

Stop phototherapy when TSB falls below 13-14 mg/dL (239 mmol/L) in infants readmitted for hyperbilirubinemia: 1

  • Rebound is rare after readmission, but consider follow-up TSB measurement 24 hours post-discharge 1
  • If phototherapy initiated early (<3-4 days old) or hemolytic disease present, obtain follow-up bilirubin within 24 hours 1

Adjunctive Therapy for Hemolytic Disease

Administer intravenous immunoglobulin (IVIG) 0.5-1 g/kg over 2 hours if TSB rising despite intensive phototherapy in isoimmune hemolytic disease: 2, 3

Essential Laboratory Evaluation

Obtain the following tests for significant neonatal hyperbilirubinemia: 2

  • TSB and direct/conjugated bilirubin
  • Blood type (ABO, Rh) and direct antibody test (Coombs') for infant and mother
  • Serum albumin (consider lower phototherapy threshold if <3.0 g/dL) 1
  • Complete blood count with differential and smear
  • Reticulocyte count
  • G6PD level if suggested by ethnicity/geography or poor phototherapy response 1, 2

Critical G6PD Considerations

Screen for G6PD deficiency in infants with significant hyperbilirubinemia, as these infants require intervention at lower TSB levels and may develop sudden TSB increases: 1, 2

  • Pitfall: G6PD levels can be falsely elevated during active hemolysis, obscuring diagnosis 1, 2
  • If G6PD deficiency strongly suspected but initial level normal during hemolysis, repeat testing at 3 months of age 1

Bilirubin/Albumin Ratio

Measure serum albumin and use bilirubin/albumin (B/A) ratio in conjunction with TSB when considering exchange transfusion: 1

  • B/A ratio is an additional factor, not a replacement for TSB level 2, 3

Critical Pitfall to Avoid

Never subtract direct (conjugated) bilirubin from total bilirubin when making treatment decisions in neonates: 2, 3

Conjugated Hyperbilirubinemia in Neonates

If conjugated bilirubin >25 μmol/L or direct bilirubin ≥50% of total bilirubin, urgent referral to pediatrician for liver disease evaluation is essential: 2, 3


ADULT HYPERBILIRUBINEMIA

Initial Diagnostic Approach

Determine whether hyperbilirubinemia is predominantly conjugated or unconjugated by obtaining fractionated bilirubin levels: 2, 3

  • Direct bilirubin >1.0 mg/dL is abnormal when TSB ≤5 mg/dL 1
  • Order complete liver function tests: ALT, AST, alkaline phosphatase, GGT, albumin 2, 3
  • Measure PT/INR to evaluate liver synthetic capacity 2, 3

Unconjugated Hyperbilirubinemia in Adults

If unconjugated fraction >70-80% of total bilirubin, consider Gilbert's syndrome—a benign condition requiring no specific treatment: 3

  • Evaluate for hemolysis with reticulocyte count, haptoglobin, and LDH 2
  • Gilbert's syndrome diagnosis: conjugated bilirubin <20-30% of total 3
  • Genetic testing for UGT1A1 mutations can provide definitive confirmation 3

Conjugated Hyperbilirubinemia in Adults

Perform abdominal ultrasound as initial imaging to evaluate for biliary obstruction (specificity 71-97%): 2, 3

  • Do not delay imaging, as early identification of biliary obstruction is critical for timely intervention 3
  • If primary sclerosing cholangitis suspected with abrupt liver test elevations, obtain MRCP or ERCP to evaluate for dominant stricture 2, 3

Preoperative Management for Biliary Obstruction

Consider preoperative biliary drainage if total bilirubin >12.8 mg/dL (218.75 μmol/L), especially if major hepatic resection planned: 2

  • For hilar cholangiocarcinoma, preoperative drainage may reduce postoperative complications when bilirubin significantly elevated 2

Critical Pitfall in Adults

Do not overinterpret albumin concentrations as a marker of liver disease severity—albumin is reduced in sepsis, inflammatory disorders, and malnutrition: 2, 3


RED FLAGS REQUIRING URGENT ATTENTION

Seek immediate evaluation for: 2

  • Signs of acute liver failure (encephalopathy, coagulopathy) with hyperbilirubinemia
  • Failure of bilirubin to decrease during phototherapy (suggests ongoing hemolysis)
  • Neonatal jaundice presenting within first 24 hours of life (pathologic) 4
  • TSB rising >5 mg/dL per day 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Elevated Total Bilirubin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated Bilirubin Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperbilirubinemia in the term newborn.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.